{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:20:30Z","timestamp":1768742430044,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.canlet.2011.12.041","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T02:47:49Z","timestamp":1326768469000},"page":"144-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically"],"prefix":"10.1016","volume":"319","author":[{"given":"Michal","family":"Zapotocky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Mejstrikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Smetana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Starkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.12.041_b0005","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/sj.leu.2402633","article-title":"Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution\u2019s experience","volume":"16","author":"Rubnitz","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2011.12.041_b0010","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.2009.25.6321","article-title":"Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98","volume":"28","author":"von Neuhoff","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.12.041_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1532\/IJH97.05075","article-title":"Runx1\/AML1 in normal and abnormal hematopoiesis","volume":"82","author":"Yamagata","year":"2005","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2011.12.041_b0020","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis","volume":"93","author":"Wang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.12.041_b0025","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/j.1460-2075.1993.tb05933.x","article-title":"The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript","volume":"12","author":"Miyoshi","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2011.12.041_b0030","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","article-title":"Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO","volume":"18","author":"Gelmetti","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0035","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","article-title":"ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors","volume":"18","author":"Lutterbach","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0040","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.12.041_b0045","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/MCB.15.4.1974","article-title":"The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation","volume":"15","author":"Meyers","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0050","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1128\/MCB.21.16.5577-5590.2001","article-title":"Dichotomy of AML1\u2013ETO functions: growth arrest versus block of differentiation","volume":"21","author":"Burel","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1079-9796(03)00021-4","article-title":"The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor","volume":"30","author":"Hiebert","year":"2003","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.canlet.2011.12.041_b0060","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.4049\/jimmunol.158.5.2251","article-title":"AML1A and AML1B can transactivate the human IL-3 promoter","volume":"158","author":"Uchida","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2011.12.041_b0065","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/MCB.16.3.1231","article-title":"CCAAT enhancer-binding protein (C\/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter","volume":"16","author":"Zhang","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2007.7","article-title":"PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis","volume":"40","author":"Huang","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2011.12.041_b0075","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1038\/sj.onc.1209638","article-title":"siRNA-mediated AML1\/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts","volume":"25","author":"Dunne","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.12.041_b0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.12.041_b0085","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2011.12.041_b0090","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2011.12.041_b0095","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/jpet.106.118406","article-title":"Targeting AML1\/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1\/ETO-positive acute myeloid leukemia cells","volume":"321","author":"Liu","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.canlet.2011.12.041_b0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"Kawagoe","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canlet.2011.12.041_b0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1349-7006.2007.00699.x","article-title":"Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera","volume":"99","author":"Sasaki","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2011.12.041_b0110","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.12.041_b0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.12.041_b0120","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.12.041_b0125","first-page":"986","article-title":"Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia","volume":"90","author":"Raffoux","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2011.12.041_b0130","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cncr.21589","article-title":"Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia","volume":"104","author":"Bug","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.12.041_b0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.acthis.2007.04.003","article-title":"Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro \u2013 a cytochemical study","volume":"109","author":"Smetana","year":"2007","journal-title":"Acta Histochem."},{"key":"10.1016\/j.canlet.2011.12.041_b0140","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-06-2569","article-title":"The identification of (ETV6)\/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6\/RUNX1-positive lymphoid leukemic cells","volume":"13","author":"Starkova","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.12.041_b0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1011-1344(00)00139-1","article-title":"The 5-aminolaevulinic acid-based photodynamic effects on nuclei and nucleoli of HL-60 leukemic granulocytic precursors","volume":"59","author":"Smetana","year":"2000","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.canlet.2011.12.041_b0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0091-679X(08)60884-5","article-title":"Methods used to study structure and function of the nucleolus","volume":"53","author":"Ochs","year":"1998","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.canlet.2011.12.041_b0155","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/86515","article-title":"AML1\u2013ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia","volume":"7","author":"Pabst","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2011.12.041_b0160","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00001813-199609000-00008","article-title":"Antitumor activity of sodium valproate in cultures of human neuroblastoma cells","volume":"7","author":"Cinatl","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2011.12.041_b0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00280-008-0747-1","article-title":"Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas","volume":"63","author":"Erlich","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2011.12.041_b0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2008-1043809","article-title":"Valproic acid for the treatment of pediatric malignant glioma","volume":"211","author":"Driever","year":"1999","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.canlet.2011.12.041_b0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/10408440591007403","article-title":"Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin \u2013 developmental effects of valproic acid","volume":"35","author":"Wiltse","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.canlet.2011.12.041_b0180","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.leu.2403390","article-title":"Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1","volume":"18","author":"Tang","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2011.12.041_b0185","first-page":"855","article-title":"Valproic acid sensitizes K562 erythroleukemia cells to TRAIL\/Apo2L-induced apoptosis","volume":"28","author":"Iacomino","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2011.12.041_b0190","article-title":"IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase","author":"Laranjeira","year":"2011","journal-title":"Leukemia."},{"key":"10.1016\/j.canlet.2011.12.041_b0195","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.12.041_b0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1078-0432.CCR-10-1707","article-title":"Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia","volume":"16","author":"Xie","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:32:31Z","timestamp":1759591951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0304383512000389"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.12.041","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2011.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}